Dr. Oana Falup-Pecurariu is Associate Professor of Pediatrics at the Faculty of Medicine, Transilvania University from Brasov, Romania. She obtained her MD degree in 1995 from the University of Medicine Iuliu Hatieganu from Cluj-Napoca, Romania and PhD in 2006 from the same University. She was chairman in conjunction of 9 European Society for Paediatric Infectious Diseases (ESPID) supported and 8 East-European and Mediterranean Teaching Courses in Brasov, Romania, with the participation of prominent researchers in pediatric infectious diseases. At present time, she is working as Head of Department at Childrens Clinic Hospital from Brasov, Associate Professor of Pediatrics at Transilvania University Brasov. She is recipient of ESPID Small Grant Award. Dr.Falup-Pecurariu was member of the International Scientific Committee of the World Society of Paediatric Infectious Diseases (WSPID) Congress in Melbourne/Australia in 2011 and in Cape Town/ South Africa in 2013, member of the International Scientific Committee of the ESPID 2015 Congress. Currently she is an ESPID Board and ESPID Education Committee Member. She spent training periods in pediatrics in Israel, Netherlands, Japan, UK.

Neha Farid is working at SZABIST as a Lecturer, Department of Biosciences, Faculty of Life Sciences. She has completed her Bachelors (Biosciences) and Masters (Biosciences) from Department of Biosciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST). She has several publications in international journals. She has presented her research piece of work at various National and International forums like Pakistan, Denmark, Spain, Malaysia, etc. She has been doing research work in the domains of Microbiology and Plant Tissue Culture. In the domain of Microbiology, she has been doing research to analyze the antimicrobial activity of the metabolites extracted from the medicinal plants such as Moringa oleifera, and determine the efficacy of the Efflux Pump Blockers in combination with the antibiotics on the various Multi-Drug Resistant Bacteria such as Methicillin Resistant Staphylococcus aureus (MRSA), Escherichia coli, etc. Along with it, she is also involved in the plant tissue culture of ornamental and medicinal plants such as Moringa oleifera. She has also earned a number of honors and academic awards. She has been awarded academic medals for being the highest CGPA achiever in her Bachelors and Masters studies. She was also the Valedictorian in the SZABIST 15th Convocation held in 2018 as she scored the highest CGPA in the graduating batch. She has been awarded Walter Marget Educational Workshop Travel to attend the 36th Annual Meeting of the European Society for Paediatric Infectious Diseases in Malmö, Sweden. Along with it, she has also been nominated by the Pakistan Institute of Engineering and Applied Sciences for participation in the 70th Lindau Nobel Laureate Meeting in Lindau, Germany (June 2020).

Saul Faust is Professor of Pediatric Immunology and Infectious Diseases at the University of Southampton in Southampton, England; Director of the National Institute for Health Research Southampton Clinical Research Facility; and Clinical Director of the NIHR Wessex Local Clinical Research Network. In the course of his research career, he has led and participated in numerous clinical trials aimed at understanding and improving the clinical management of paediatric infectious diseases, with a special interest in the development of new vaccines.

Kristen A. Feemster, MD MPH MSHP is a Global Director, Medical Affairs for pneumococcal vaccines at Merck Research Laboratories, Merck & Co., Inc. and Adjunct Associate Professor of Pediatrics – Infectious Diseases at the University of Pennsylvania (UPenn) Perelman School of Medicine. A board-certified pediatric infectious diseases physician and health services researcher, Dr. Feemster received an M.D. / M.P.H. at Columbia University and completed residency and fellowship training at the Children’s Hospital of Philadelphia (CHOP) where she joined the Division of Infectious Diseases in 2010. She has led a research portfolio focusing upon vaccine policy and the epidemiology of vaccine preventable diseases both domestically and internationally, serving as the Research Director of the Vaccine Education Center at CHOP. After several years in academic medicine, she transitioned to a full-time role as Medical Director of the Immunization Program and Acute Communicable Diseases at the Philadelphia Department of Public Health until starting her current position at Merck & Co., Inc. in June 2020.

Elisa Fernandez-Cooke trained as a paediatrician, focusing on infectious diseases in Hospital 12 de Octubre, Spain (2006-2010). Her thesis on “Off-label antiretrovirals in paediatrics” was presented at Universidad Complutense (2014), Madrid. Clinical fellow in paediatric infectious diseases and haem-oncology at St Marys Hospital, London (2010-2012). She worked as a community paediatrician in Madrid during 2013. During 2014 she participated for in a HIV research project in Mozambique for Centro de Investigação em Saúde de Manhiça (CISM). From April 2014 to date she has been working as a consultant paediatrician in paediatric infectious diseases at Hospital 12 de Octubre in Madrid. She has been a Young ESPID educational committee member (2012-2018), regular ESPID educational committee member (2018-2020) and young ESPID representative participating in the board (2015-2018). Research interests include bone and joint infections and Kawasaki disease.

My name is Kinga Fiebig and in May I started as the first PhD student in the pharmacy group within the Leiden Academic Centre for Drug Research. My aim is to gain a deeper understanding of neonatal sepsis through computational modelling, under the supervision of Dr. Swantje Völler, Prof. Wim Jiskoot and Prof. Catherijne Knibbe. Within this project, we will look into different relevant aspects of neonatal sepsis while focusing on a new potential drug candidate for the treatment of neonatal sepsis, pentoxifylline.

I am an NIHR Academic Clinical Lecturer in paediatric infectious diseases, currently based between London and Zimbabwe working on projects around antimicrobial resistance and ways of limiting spread both in hospitals and communities. I am particularly interested in infection prevention control in under-resourced settings. My PhD investigated microbial translocation in HIV-infected children in Uganda, using molecular methods to test for bacterial DNA in blood, supervised by Nigel Klein. I spent several months in Sierra Leone during the West African Ebola virus disease (EVD) crisis working clinically and developing a cohort study of >1000 children admitted to Ebola holding units with suspected EVD. This project has resulted in several original research papers and three national level awards.

2017: Integrated Master’s Degree in Medicine, Faculty of Medicine, University of Lisbon, Portugal 2019: General Training (Internship), Barreiro-Montijo Hospital Center, Portugal 2020: Admission to the Pediatrics Training Residency, Setúbal Hospital Center, Portugal October-to-December 2020: Internship at Pediatric Infectious Diseases Unit, Hospital Dona Estefânia. CHLC-EPE Lisboa. Portugal

i am a paediatric specialist registrar working in Dublin, Ireland. I have completed diplomas in Troplcal Medicine and in Paediatric Infectious Disease. During my training I have also worked abroad with Médecins Sans Frontieres in Syria. I plan to sub-specialise in paediatric infectious disease, with an interest in migrant and refugee health.

Dr Yves Fougere is actually Senior resident in Pediatric Infectious Diseases and Vaccinology Unit in Lausanne University Hospital. After completing his Swiss Pediatric Board exam in 2020 and obtaining a University Diploma (DU in Pediatric Infectious Diseases at the University of Paris Descartes France) in 2019 Dr. Yves Fougere completed almost a 3-year clinical experience in Pediatric Infectious Diseases at the Lausanne University Hospital.

I am a pediatrician, currently working as an assistant specialist in pediatric infectious diseases. I’m part of the mobile team of pediatric infectious diseases of the university hospital of Lille directed by Pr DUBOS. My second year of assistantship will take place at the Mayotte hospital (at Dr CHAMOUINE's department) where I already had the opportunity to work. I completed two inter-university diplomas in infectiology, amongst which a diploma in pediatric infectiology proposed by Pr GRIMPREL and another in therapeutic and preventive strategy in infectious diseases. I’m now doing the second and final year of a complementary specialized study diploma in infectious and tropical diseases. During my residency, I did a 6 months internship in the infectious and tropical disease department of Pr CAZANAVE at the Bordeaux University Hospital and another in the mycology and parasitology laboratory of the same hospital, directed by Pr DELHAES. I also obtained a first year of master's degree in the field of infectious diseases in the same department.

I am a U.K. trained junior doctor, working in Australia. I have a passion for global health and research within infectious diseases.

Professor. Robert Frenck is a Professor of Pediatrics in the Division of Infectious Diseases at Cincinnati Children’s Hospital Medical Center (CCHMC). He earned a BA in Biology from the University of California at San Diego and his medical degree at the University of Texas Health Science Center at Houston (UTHSC). He completed a residency in Pediatrics at the National Naval Medical Center in Bethesda, Maryland, and a fellowship in Pediatric Infectious Diseases at UTHSC. Professor Frenck is the Director of the James Gamble Center for Vaccine Research at CCHMC, as well as the Principal Investigator (PI) of the National Institutes of Health (NIH)-funded Vaccine and Treatment Evaluation Unit (VTEU) at CCHMC. He is a recognized expert in conducting clinical trials, with particular emphasis on enteric diseases, and has published over 125 manuscripts in the peer-reviewed literature. Professor Frenck was the site PI for the Phase 1 Pfizer/BioNTech SARS-CoV-2 vaccine as well as one of five investigators in the US evaluating the SARS-CoV-2 vaccine in adolescents. As part of Operation Warp Speed, Professor Frenck is currently the site PI for the AstraZeneca SARS-CoV-2 vaccine.